Fresenius | FRE - Selling And Administration Expenses

Stock Price
51.89
Daily Change
-0.17 -0.33%
Monthly
7.95%
Yearly
42.01%
Q1 Forecast
50.68

Fresenius reported EUR676M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 865M 5M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.2B 384M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Beiersdorf EUR 322M 1.68B Jun/2025
DaVita Healthcare Partners USD 472.36M 57.99M Dec/2025
Demant DKK 6.09B 135M Dec/2025
E.ON EUR -1.71B 3.63B Jun/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Getinge SEK 2.65B 452M Dec/2024
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GN Store Nord DKK 1.45B 41M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
RWE EUR 690M 84M Mar/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025